These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New connection method for isolating and disinfecting intraluminal path during peritoneal dialysis solution-exchange procedures. Grabowy RS; Kelley R; Richter SG; Bousquet GG; Carr KL Adv Perit Dial; 1998; 14():149-53. PubMed ID: 10649714 [TBL] [Abstract][Full Text] [Related]
4. In vitro study of the efficacy of a two-way connection with disinfectant in the prevention of peritonitis. Buoncristiani U; Bianchi P; Nasimi M; Parlani F; Covarelli C; Buoncristiani E; Bastianini L; Bistoni F Adv Perit Dial; 2000; 16():208-12. PubMed ID: 11045295 [TBL] [Abstract][Full Text] [Related]
5. Heat sterilisation of Safe-Lock connectors using the Thermoclave. Thomae U Contrib Nephrol; 1987; 57():172-7. PubMed ID: 3315439 [No Abstract] [Full Text] [Related]
6. Microbicidal efficacy of povidone-iodine in a noncontact manner applied to a continuous ambulatory peritoneal dialysis connection system. Kashiwagi T; Iino Y; Miyahara H; Katayama Y J Nippon Med Sch; 2010 Apr; 77(2):86-92. PubMed ID: 20453420 [TBL] [Abstract][Full Text] [Related]
7. [Replacement of the peritoneal dialysis catheter in persistent peritonitis in continuous ambulatory peritoneal dialysis]. Marichal JF; Faller B; Mengus C; Wagner JD; Frey G Nephrologie; 1985; 6(1):7-10. PubMed ID: 4000380 [TBL] [Abstract][Full Text] [Related]
8. 'Y' connector system for prevention of peritonitis in CAPD: a controlled study. Maiorca R; Cantaluppi A; Cancarini GC; Scalamogna A; Strada A; Graziani G; Brasa S; Ponticelli C Proc Eur Dial Transplant Assoc; 1983; 20():223-9. PubMed ID: 6361737 [TBL] [Abstract][Full Text] [Related]
9. Reduction of the incidence of peritonitis in CAPD: effectiveness of heat sterilization of Safe. Lock connectors. Olivas E; Jiménez C; López A; Andres E; Sánchez Tárraga L Contrib Nephrol; 1991; 89():62-7. PubMed ID: 1893744 [No Abstract] [Full Text] [Related]
10. Prevention of peritonitis during continuous ambulatory peritoneal dialysis (CAPD) by Y-connected double bag systems. Wüst J; Binswanger U; Bichsel G Life Support Syst; 1985; 3 Suppl 1():107-11. PubMed ID: 3870548 [No Abstract] [Full Text] [Related]
11. The influence of seasonal factors on the incidence of peritonitis in continuous ambulatory peritoneal dialysis in the temperate zone. Kim MJ; Song JH; Park YJ; Kim GA; Lee SW Adv Perit Dial; 2000; 16():243-7. PubMed ID: 11045303 [TBL] [Abstract][Full Text] [Related]
12. [Laparoscopic implantation of catheters for continuous ambulatory peritoneal dialysis]. Witzigmann H; Richter O; Kohlhaw K; Achenbach H; Otto M; Hauss J Zentralbl Chir; 1998; 123(1):76-9. PubMed ID: 9542035 [TBL] [Abstract][Full Text] [Related]
13. Biofilm formation and changes in bacterial cell surface hydrophobicity during growth in a CAPD model system. Hanlon GW; Denyer SP; Hodges NA; Brant JA; Lansley AB; Al-Rustamani WA J Pharm Pharmacol; 2004 Jul; 56(7):847-54. PubMed ID: 15233862 [TBL] [Abstract][Full Text] [Related]
14. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis. Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719 [TBL] [Abstract][Full Text] [Related]
16. An antimicrobial modified silicone peritoneal catheter with activity against both Gram-positive and Gram-negative bacteria. Bayston R; Fisher LE; Weber K Biomaterials; 2009 Jun; 30(18):3167-73. PubMed ID: 19289248 [TBL] [Abstract][Full Text] [Related]
17. [Transperitoneal resorption of cefotiam in CAPD patients with and without peritonitis]. Thomae U; Koblinger S Med Klin (Munich); 1994 Sep; 89(9):464-8. PubMed ID: 7968880 [TBL] [Abstract][Full Text] [Related]
18. Intracatheter streptokinase for recurrent peritonitis in CAPD. Nankivell BJ; Lake N; Gillies A Clin Nephrol; 1991 Jan; 35(1):20-3. PubMed ID: 2007292 [TBL] [Abstract][Full Text] [Related]
19. Treatment of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Horton MW; Deeter RG; Sherman RA Clin Pharm; 1990 Feb; 9(2):102-18. PubMed ID: 2407420 [TBL] [Abstract][Full Text] [Related]
20. Infection rates in end-stage renal disease patients treated with CCPD and CAPD using the UltraBag system. Ghahramani N; Gorban-Brennan N; Kliger AS; Finkelstein FO Adv Perit Dial; 1995; 11():164-7. PubMed ID: 8534695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]